Like its competitors, the company was anxious to capitalise on a growing market for chronic conditions and enthused by the high profit potential from patent protected drugs, and all in all the major pharmaceutical companies screened hundreds of compounds seeking a less toxic, more effective alternative to available treatments for acute and chronic inflammatory conditions best site to buy priligy